Home › Funds › DIADEMA PARTNERS LP › BIIB
DIADEMA PARTNERS LP position in BIIB
BIOGEN INC · Health Care
DIADEMA PARTNERS LP reported holding 60,000 shares of BIIB (BIOGEN INC) in its Q2 2026 13F filing — a position valued at US$13.0M, representing 2.82% of its reported portfolio and ranking #11 among its reported holdings. DIADEMA PARTNERS LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DIADEMA PARTNERS LP's BIIB position evolved
DIADEMA PARTNERS LP first disclosed a stake in BIIB in Q2 2026 at 60,000 shares (US$13.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 60.00K | $12.96M | New |
About BIIB and 13F data
BIIB (BIOGEN INC) is a Health Care company. 22 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BIIB
- PRIMECAP MANAGEMENT CO/CA/ 15.15M sh · $3.27B · Q2 2026
More on DIADEMA PARTNERS LP
FAQ
How long has DIADEMA PARTNERS LP held BIIB?
DIADEMA PARTNERS LP has disclosed BIIB holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is DIADEMA PARTNERS LP's current position in BIIB?
As of Q2 2026, DIADEMA PARTNERS LP holds 60.00K shares of BIIB (BIOGEN INC), valued at $12.96M, representing 2.82% of its reported portfolio and ranking #11.
Has DIADEMA PARTNERS LP been buying or selling BIIB?
In the latest 13F filing (Q2 2026), DIADEMA PARTNERS LP newly opened its position in BIIB.
Which other funds hold BIIB?
Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.